Cost-of-illness  ||| S:0 E:16 ||| JJ
of  ||| S:16 E:19 ||| IN
rheumatoid  ||| S:19 E:30 ||| JJ
arthritis  ||| S:30 E:40 ||| NN
and  ||| S:40 E:44 ||| CC
ankylosing  ||| S:44 E:55 ||| JJ
spondylitis  ||| S:55 E:67 ||| NN
To  ||| S:67 E:70 ||| TO
assess ||| S:70 E:76 ||| VB
,  ||| S:76 E:78 ||| ,
quantify  ||| S:78 E:87 ||| NN
and  ||| S:87 E:91 ||| CC
summarise  ||| S:91 E:101 ||| VBG
the  ||| S:101 E:105 ||| DT
cost  ||| S:105 E:110 ||| NN
of  ||| S:110 E:113 ||| IN
illness  ||| S:113 E:121 ||| NN
of  ||| S:121 E:124 ||| IN
rheumatoid  ||| S:124 E:135 ||| JJ
arthritis  ||| S:135 E:145 ||| NN
( ||| S:145 E:146 ||| -LRB-
RA ||| S:146 E:148 ||| NNP
)  ||| S:148 E:150 ||| -RRB-
and  ||| S:150 E:154 ||| CC
ankylosing  ||| S:154 E:165 ||| JJ
spondylitis  ||| S:165 E:177 ||| NNS
( ||| S:177 E:178 ||| -LRB-
AS ||| S:178 E:180 ||| NNP
)  ||| S:180 E:182 ||| -RRB-
from  ||| S:182 E:187 ||| IN
the  ||| S:187 E:191 ||| DT
societal  ||| S:191 E:200 ||| JJ
perspective ||| S:200 E:211 ||| NN
.  ||| S:211 E:213 ||| .
Original  ||| S:213 E:222 ||| JJ
studies  ||| S:222 E:230 ||| NNS
reporting  ||| S:230 E:240 ||| VBG
costs  ||| S:240 E:246 ||| NNS
of  ||| S:246 E:249 ||| IN
RA  ||| S:249 E:252 ||| NNP
or  ||| S:252 E:255 ||| CC
AS  ||| S:255 E:258 ||| NNP
were  ||| S:258 E:263 ||| VBD
searched  ||| S:263 E:272 ||| JJ
systematically ||| S:272 E:286 ||| NN
.  ||| S:286 E:288 ||| .
Both  ||| S:288 E:293 ||| DT
cost-of-illness  ||| S:293 E:309 ||| JJ
studies  ||| S:309 E:317 ||| NNS
and  ||| S:317 E:321 ||| CC
economic  ||| S:321 E:330 ||| JJ
evaluations  ||| S:330 E:342 ||| NNS
of  ||| S:342 E:345 ||| IN
therapies  ||| S:345 E:355 ||| NNS
were  ||| S:355 E:360 ||| VBD
included ||| S:360 E:368 ||| VBN
.  ||| S:368 E:370 ||| .
Studies  ||| S:370 E:378 ||| NNS
were  ||| S:378 E:383 ||| VBD
appraised  ||| S:383 E:393 ||| VBN
for  ||| S:393 E:397 ||| IN
patient  ||| S:397 E:405 ||| NN
and  ||| S:405 E:409 ||| CC
study  ||| S:409 E:415 ||| NN
characteristics ||| S:415 E:430 ||| NNS
,  ||| S:430 E:432 ||| ,
type  ||| S:432 E:437 ||| NN
of  ||| S:437 E:440 ||| IN
costs  ||| S:440 E:446 ||| NNS
and  ||| S:446 E:450 ||| CC
actual  ||| S:450 E:457 ||| JJ
costs ||| S:457 E:462 ||| NNS
.  ||| S:462 E:464 ||| .
Reported  ||| S:464 E:473 ||| VBN
costs  ||| S:473 E:479 ||| NNS
were  ||| S:479 E:484 ||| VBD
aggregated  ||| S:484 E:495 ||| VBN
by  ||| S:495 E:498 ||| IN
cost  ||| S:498 E:503 ||| NN
categories  ||| S:503 E:514 ||| NNS
and  ||| S:514 E:518 ||| CC
overall  ||| S:518 E:526 ||| JJ
mean  ||| S:526 E:531 ||| JJ
costs  ||| S:531 E:537 ||| NNS
were  ||| S:537 E:542 ||| VBD
summarised  ||| S:542 E:553 ||| VBN
by  ||| S:553 E:556 ||| IN
cost  ||| S:556 E:561 ||| NN
domain  ||| S:561 E:568 ||| NN
( ||| S:568 E:569 ||| -LRB-
healthcare ||| S:569 E:579 ||| UH
,  ||| S:579 E:581 ||| ,
patient  ||| S:581 E:589 ||| NN
and  ||| S:589 E:593 ||| CC
family ||| S:593 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
and  ||| S:601 E:605 ||| CC
productivity  ||| S:605 E:618 ||| NN
costs ||| S:618 E:623 ||| NNS
) ||| S:623 E:624 ||| -RRB-
.  ||| S:624 E:626 ||| .
Overall  ||| S:626 E:634 ||| RB
mean  ||| S:634 E:639 ||| VB
costs  ||| S:639 E:645 ||| NNS
of  ||| S:645 E:648 ||| IN
RA  ||| S:648 E:651 ||| NNP
( ||| S:651 E:652 ||| -LRB-
euro14,906  ||| S:652 E:663 ||| FW
per  ||| S:663 E:667 ||| FW
year ||| S:667 E:671 ||| NN
)  ||| S:671 E:673 ||| -RRB-
were  ||| S:673 E:678 ||| VBD
above  ||| S:678 E:684 ||| IN
that  ||| S:684 E:689 ||| DT
of  ||| S:689 E:692 ||| IN
AS  ||| S:692 E:695 ||| NNP
( ||| S:695 E:696 ||| -LRB-
euro9,374  ||| S:696 E:706 ||| FW
per  ||| S:706 E:710 ||| FW
year ||| S:710 E:714 ||| NN
) ||| S:714 E:715 ||| -RRB-
,  ||| S:715 E:717 ||| ,
while  ||| S:717 E:723 ||| IN
the  ||| S:723 E:727 ||| DT
relative  ||| S:727 E:736 ||| JJ
distribution  ||| S:736 E:749 ||| NN
of  ||| S:749 E:752 ||| IN
costs  ||| S:752 E:758 ||| NNS
over  ||| S:758 E:763 ||| IN
cost  ||| S:763 E:768 ||| NN
domains  ||| S:768 E:776 ||| NNS
was  ||| S:776 E:780 ||| VBD
approximately  ||| S:780 E:794 ||| RB
similar ||| S:794 E:801 ||| JJ
.  ||| S:801 E:803 ||| .
For  ||| S:803 E:807 ||| IN
both  ||| S:807 E:812 ||| DT
diseases ||| S:812 E:820 ||| NNS
,  ||| S:820 E:822 ||| ,
productivity  ||| S:822 E:835 ||| NN
costs  ||| S:835 E:841 ||| VBZ
based  ||| S:841 E:847 ||| VBN
on  ||| S:847 E:850 ||| IN
the  ||| S:850 E:854 ||| DT
human  ||| S:854 E:860 ||| JJ
cost  ||| S:860 E:865 ||| NN
approach  ||| S:865 E:874 ||| NN
were  ||| S:874 E:879 ||| VBD
3  ||| S:879 E:881 ||| CD
to  ||| S:881 E:884 ||| TO
10  ||| S:884 E:887 ||| CD
times  ||| S:887 E:893 ||| NNS
higher  ||| S:893 E:900 ||| JJR
than  ||| S:900 E:905 ||| IN
the  ||| S:905 E:909 ||| DT
friction  ||| S:909 E:918 ||| NN
costs  ||| S:918 E:924 ||| NNS
and  ||| S:924 E:928 ||| CC
accounted  ||| S:928 E:938 ||| VBD
for  ||| S:938 E:942 ||| IN
more  ||| S:942 E:947 ||| JJR
than  ||| S:947 E:952 ||| IN
half  ||| S:952 E:957 ||| PDT
the  ||| S:957 E:961 ||| DT
total  ||| S:961 E:967 ||| JJ
costs  ||| S:967 E:973 ||| NNS
of  ||| S:973 E:976 ||| IN
both  ||| S:976 E:981 ||| DT
diseases ||| S:981 E:989 ||| NNS
.  ||| S:989 E:991 ||| .
Productivity  ||| S:991 E:1004 ||| NN
costs  ||| S:1004 E:1010 ||| NNS
constitute  ||| S:1010 E:1021 ||| VBP
the  ||| S:1021 E:1025 ||| DT
largest  ||| S:1025 E:1033 ||| JJS
part  ||| S:1033 E:1038 ||| NN
of  ||| S:1038 E:1041 ||| IN
the  ||| S:1041 E:1045 ||| DT
total  ||| S:1045 E:1051 ||| JJ
cost-off-illness  ||| S:1051 E:1068 ||| NN
of  ||| S:1068 E:1071 ||| IN
RA  ||| S:1071 E:1074 ||| NNP
and  ||| S:1074 E:1078 ||| CC
AS  ||| S:1078 E:1081 ||| IN
reflecting  ||| S:1081 E:1092 ||| VBG
the  ||| S:1092 E:1096 ||| DT
high  ||| S:1096 E:1101 ||| JJ
burden  ||| S:1101 E:1108 ||| NN
of  ||| S:1108 E:1111 ||| IN
the  ||| S:1111 E:1115 ||| DT
disease  ||| S:1115 E:1123 ||| NN
on  ||| S:1123 E:1126 ||| IN
work  ||| S:1126 E:1131 ||| NN
participation ||| S:1131 E:1144 ||| NN
.  ||| S:1144 E:1146 ||| .
Although  ||| S:1146 E:1155 ||| IN
total  ||| S:1155 E:1161 ||| JJ
and  ||| S:1161 E:1165 ||| CC
direct  ||| S:1165 E:1172 ||| JJ
costs  ||| S:1172 E:1178 ||| NNS
of  ||| S:1178 E:1181 ||| IN
illness  ||| S:1181 E:1189 ||| NN
in  ||| S:1189 E:1192 ||| IN
RA  ||| S:1192 E:1195 ||| NNP
were  ||| S:1195 E:1200 ||| VBD
higher  ||| S:1200 E:1207 ||| JJR
than  ||| S:1207 E:1212 ||| IN
in  ||| S:1212 E:1215 ||| IN
AS ||| S:1215 E:1217 ||| NNP
,  ||| S:1217 E:1219 ||| ,
the  ||| S:1219 E:1223 ||| DT
average  ||| S:1223 E:1231 ||| JJ
age  ||| S:1231 E:1235 ||| NN
of  ||| S:1235 E:1238 ||| IN
AS  ||| S:1238 E:1241 ||| NNP
patients  ||| S:1241 E:1250 ||| NNS
was  ||| S:1250 E:1254 ||| VBD
10  ||| S:1254 E:1257 ||| CD
years  ||| S:1257 E:1263 ||| NNS
lower  ||| S:1263 E:1269 ||| JJR
and  ||| S:1269 E:1273 ||| CC
therefore ||| S:1273 E:1282 ||| RB
,  ||| S:1282 E:1284 ||| ,
lifetime  ||| S:1284 E:1293 ||| NN
costs  ||| S:1293 E:1299 ||| VBZ
associated  ||| S:1299 E:1310 ||| VBN
with  ||| S:1310 E:1315 ||| IN
AS  ||| S:1315 E:1318 ||| NNP
may  ||| S:1318 E:1322 ||| MD
actually  ||| S:1322 E:1331 ||| RB
be  ||| S:1331 E:1334 ||| VB
equal  ||| S:1334 E:1340 ||| JJ
or  ||| S:1340 E:1343 ||| CC
higher ||| S:1343 E:1349 ||| JJR
.  ||| S:1349 E:1351 ||| .
